NCT05271097Active, not recruiting
MHealth HIV Prevention for Transgender Women
Developing a MHealth HIV Prevention Intervention for Transgender Women (Phase 1 and 2)
Source: ClinicalTrials.gov · Last updated 18 Mar 2025
Brief summary (registry, in English)
This study aims to inform the development of an acceptable and usable smartphone app for transgender women (TGW) in Malaysia to deliver an integrated HIV prevention intervention that incorporates screening and guidance for HIV testing and pre-exposure prophylaxis compared to treatment as usual.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 24 Feb 2022
- Start date
- 12 Jul 2023
- Primary completion date
- Mar 2025
- Lead sponsor
- Yale University
- Diseases
- HIV
- NCT number
- NCT05271097
What you commit to
- Study type: Interventional
- Participants enrolled: 50
- From 12 Jul 2023 to the primary completion date, Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unable to provide informed consent
- Unable to read and understand English or Bahasa Malaysia
Who the study is looking for
- HIV-negative
- Identify as a transgender woman
- Condomless sex in the last 30 days
- Own a smartphone
Age in the registry: 18 years to - · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Malaya Coordinator of this site? Confirm its status | Kuala Lumpur | Malaysia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.